Amedisys, Inc. (NASDAQ:AMED) Shares Bought by Allianz Asset Management GmbH

Allianz Asset Management GmbH grew its stake in shares of Amedisys, Inc. (NASDAQ:AMEDFree Report) by 146.0% in the fourth quarter, Holdings reports. The fund owned 39,855 shares of the health services provider’s stock after purchasing an additional 23,655 shares during the period. Allianz Asset Management GmbH’s holdings in Amedisys were worth $3,789,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of AMED. Cetera Trust Company N.A purchased a new stake in shares of Amedisys in the 4th quarter worth about $215,000. CWM LLC raised its position in shares of Amedisys by 40.4% during the 4th quarter. CWM LLC now owns 2,629 shares of the health services provider’s stock worth $250,000 after purchasing an additional 757 shares during the last quarter. Contravisory Investment Management Inc. purchased a new stake in Amedisys in the 4th quarter valued at approximately $258,000. Mesirow Institutional Investment Management Inc. grew its holdings in Amedisys by 9.9% during the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider’s stock valued at $270,000 after buying an additional 257 shares during the last quarter. Finally, Federated Hermes Inc. increased its position in Amedisys by 32.9% during the fourth quarter. Federated Hermes Inc. now owns 3,518 shares of the health services provider’s stock worth $334,000 after buying an additional 871 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on AMED shares. Cantor Fitzgerald restated a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a research report on Thursday, April 25th. raised shares of Amedisys from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Royal Bank of Canada lifted their price target on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, March 25th. Finally, Raymond James reissued a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Six investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $100.80.

Read Our Latest Stock Analysis on Amedisys

Amedisys Stock Down 0.3 %

Shares of NASDAQ:AMED opened at $91.45 on Friday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. The firm has a market cap of $2.99 billion, a price-to-earnings ratio of -142.89, a PEG ratio of 2.27 and a beta of 0.80. The stock’s 50-day moving average price is $93.13 and its two-hundred day moving average price is $93.66. Amedisys, Inc. has a 12-month low of $89.55 and a 12-month high of $97.36.

Amedisys (NASDAQ:AMEDGet Free Report) last released its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The business had revenue of $571.41 million for the quarter, compared to analysts’ expectations of $565.38 million. During the same period last year, the company earned $1.00 earnings per share. The company’s quarterly revenue was up 2.7% on a year-over-year basis. On average, research analysts forecast that Amedisys, Inc. will post 4.57 EPS for the current year.

About Amedisys

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

See Also

Want to see what other hedge funds are holding AMED? Visit to get the latest 13F filings and insider trades for Amedisys, Inc. (NASDAQ:AMEDFree Report).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with's FREE daily email newsletter.